Literature DB >> 29080145

Role of Angiogenesis in Chronic Radiation Proctitis: New Evidence Favoring Inhibition of Angiogenesis Ex Vivo.

Peihuang Wu1,2, Li Li1,2, Huaiming Wang3, Tenghui Ma3, Haiyong Wu1,2, Xinjuan Fan4, Zihuan Yang1,2, Daici Chen5,6, Lei Wang7,8,9.   

Abstract

BACKGROUND: Chronic radiation proctitis (CRP), a common complication after radiotherapy for pelvic malignancies, compromises patient quality of life. Vascular damage and aberrant angiogenesis in the mucosal layer are essential histological features, but changes to the submucosal layer are unclear. Thus, we evaluated the histological characteristics and distribution changes of key angiogenic factors in full-layered human CRP samples.
METHODS: Thirty paraffin-embedded CRP and twenty-nine non-CRP tissues were used to evaluate histopathological changes. Immunohistochemistry with anti-CD34 antibody was performed to calculate microvascular density (MVD). Frozen tissues from eight CRP patients and five non-CRP controls were collected and analyzed by antibody array, which contained sixty human angiogenesis-related factors. Quality controls with positive and negative controls were performed during antibody array analysis. Two differentially expressed factors were confirmed by ELISA.
RESULTS: CRP lesions showed vasculopathy, fibrosis, mucosal ulceration, edema, and inflammatory cell infiltration. Human angiogenesis antibody array and ELISA confirmed the increased angiostatin in CRP lesions. Immunohistochemical staining showed dispersed distribution of angiostatin throughout the mucosal and submucosal layers in CRP lesions, while angiostatin accumulated within the vessel lumens in non-CRP tissues. MVD significantly decreased in the submucosal layer of CRP, suggesting a potential association with increased angiostatin.
CONCLUSIONS: Angiostatin increased and had a distinct distribution in CRP lesions. Compensatory telangiectasia in the mucosa, vessel stenosis, and reduced MVD might attenuate blood flow in the submucosa and contribute to CRP progression. Restoration of vascular functionality by promoting angiogenesis in the submucosal layer may help alleviate CRP in clinical practice.

Entities:  

Keywords:  Angiogenesis; Angiostatin; Chronic radiation proctitis; Radiotherapy

Mesh:

Substances:

Year:  2017        PMID: 29080145     DOI: 10.1007/s10620-017-4818-1

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  49 in total

Review 1.  Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology.

Authors:  Søren M Bentzen
Journal:  Nat Rev Cancer       Date:  2006-09       Impact factor: 60.716

2.  Angiostatin decreases cell migration and vascular endothelium growth factor (VEGF) to pigment epithelium derived factor (PEDF) RNA ratio in vitro and in a murine ocular melanoma model.

Authors:  Hua Yang; Zuping Xu; P Michael Iuvone; Hans E Grossniklaus
Journal:  Mol Vis       Date:  2006-05-22       Impact factor: 2.367

3.  Reduced expression of vascular endothelial growth factor paralleled with the increased angiostatin expression resulting from the upregulated activities of matrix metalloproteinase-2 and -9 in human type 2 diabetic arterial vasculature.

Authors:  Ada W Y Chung; York N Hsiang; Lise A Matzke; Bruce M McManus; Cornelis van Breemen; Elena B Okon
Journal:  Circ Res       Date:  2006-06-15       Impact factor: 17.367

4.  Enhanced antitumour efficacy by combining conventional chemotherapy with angiostatin or endostatin in a liver metastasis model.

Authors:  E A te Velde; J M Vogten; M F G B Gebbink; J M van Gorp; E E Voest; I H M Borel Rinkes
Journal:  Br J Surg       Date:  2002-10       Impact factor: 6.939

5.  A mechanism for abnormal angiogenesis in human radiation proctitis: analysis of expression profile for angiogenic factors.

Authors:  Hisashi Takeuchi; Tetsuo Kimura; Koichi Okamoto; Eriko Aoyagi; Hiroshi Miyamoto; Masako Kaji; Hidetaka Takenaka; Seisuke Okamura; Yasushi Sato; Junji Kato; Toshiya Okahisa; Tetsuji Takayama
Journal:  J Gastroenterol       Date:  2011-11-15       Impact factor: 7.527

6.  Radiation colitis and proctitis.

Authors:  Gregory D Kennedy; Charles P Heise
Journal:  Clin Colon Rectal Surg       Date:  2007-02

Review 7.  Treatment of radiation proctitis.

Authors:  K Leiper; A I Morris
Journal:  Clin Oncol (R Coll Radiol)       Date:  2007-08-28       Impact factor: 4.126

8.  Prolonged treatment with angiostatin reduces metastatic burden during radiation therapy.

Authors:  David H Gorski; Helena J Mauceri; Rabih M Salloum; Arielle Halpern; Saraswathy Seetharam; Ralph R Weichselbaum
Journal:  Cancer Res       Date:  2003-01-15       Impact factor: 12.701

9.  Angiostatin regulates the expression of antiangiogenic and proapoptotic pathways via targeted inhibition of mitochondrial proteins.

Authors:  Tong-Young Lee; Stefan Muschal; Elke A Pravda; Judah Folkman; Amir Abdollahi; Kashi Javaherian
Journal:  Blood       Date:  2009-05-22       Impact factor: 22.113

Review 10.  Wound healing after radiation therapy: review of the literature.

Authors:  Frank Haubner; Elisabeth Ohmann; Fabian Pohl; Jürgen Strutz; Holger G Gassner
Journal:  Radiat Oncol       Date:  2012-09-24       Impact factor: 3.481

View more
  3 in total

1.  To what extent should the intestinal be resected proximally after radiotherapy: hint from a pathological view.

Authors:  Pei-Huang Wu; Qing-Hua Zhong; Teng-Hui Ma; Qi-Yuan Qin; Xiao-Yan Huang; Ying-Yi Kuang; Huai-Ming Wang; Zi-Xu Yuan; Lei Wang; Dai-Ci Chen
Journal:  Gastroenterol Rep (Oxf)       Date:  2019-10-16

2.  The dynamic cellular and molecular features during the development of radiation proctitis revealed by transcriptomic profiling in mice.

Authors:  Qingzhi Zeng; Jingyang Cheng; Haiyong Wu; Wenfeng Liang; Yanmei Cui
Journal:  BMC Genomics       Date:  2022-06-09       Impact factor: 4.547

3.  Novel mechanisms underlying inhibition of inflammation-induced angiogenesis by dexamethasone and gentamicin via PI3K/AKT/NF-κB/VEGF pathways in acute radiation proctitis.

Authors:  Yousong Li; Qin Ding; Jinsheng Gao; Chunxia Li; Pengxiao Hou; Jie Xu; Kaiqi Cao; Min Hu; Lin Cheng; Xixing Wang; Xiaoling Yang
Journal:  Sci Rep       Date:  2022-08-18       Impact factor: 4.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.